zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
doxorubicin teva 2mg/ml
pliva ljubljana d.o.o., ljubljana - raztopina za injiciranje - doksorubicin
doxorubicin pliva prašek za raztopino za injiciranje/infundiranje 10 mg
prašek za raztopino za injiciranje ali infundiranje - doksorubicin
doxorubicin pliva prašek za raztopino za injiciranje/infundiranje 50 mg
prašek za raztopino za injiciranje ali infundiranje - doksorubicin
doxorubicin pliva prašek za raztopino za injiciranje/infundiranje 10 mg
prašek za raztopino za injiciranje ali infundiranje - doksorubicin
doksorubicin agila specialties 2 mg/ml koncentrat za raztopino za infundiranje
agila specialties uk limited - doksorubicin - koncentrat za raztopino za infundiranje - doksorubicin 1,88 mg / 1 ml - doksorubicin
doksorubicin agila specialties 2 mg/ml koncentrat za raztopino za infundiranje
agila specialties uk limited - doksorubicin - koncentrat za raztopino za infundiranje - doksorubicin 1,88 mg / 1 ml - doksorubicin
doksorubicin agila specialties 2 mg/ml koncentrat za raztopino za infundiranje
agila specialties uk limited - doksorubicin - koncentrat za raztopino za infundiranje - doksorubicin 1,88 mg / 1 ml - doksorubicin
doksorubicin agila specialties 2 mg/ml koncentrat za raztopino za infundiranje
agila specialties uk limited - doksorubicin - koncentrat za raztopino za infundiranje - doksorubicin 1,88 mg / 1 ml - doksorubicin
doksorubicin teva 2 mg/ml koncentrat za raztopino za infundiranje
teva pharma b.v. - doksorubicin - koncentrat za raztopino za infundiranje - doksorubicin 1,88 mg / 1 ml - doksorubicin